However, no significant changes in iWAT weight or thermogenic gene expression were observed after 2 weeks of rivastigmine treatment (Fig 4J), suggesting that acute inhibition of acetylcholine degradation is insufficient to fully activate adipose CHRNA2 signaling, particularly in obesity, when beige adipocyte activity is repressed. This evidence concerns the gene CHRNA2 and Obesity.